↑Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y (Feb 2002). "Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells". Oncogene. 21 (8): 1295–8. doi:10.1038/sj.onc.1205171. PMID11850849.
Nagase T, Seki N, Ishikawa K, Ohira M, Kawarabayasi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N (Oct 1996). "Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain". DNA Research. 3 (5): 321–9, 341–54. doi:10.1093/dnares/3.5.321. PMID9039502.
Chano T, Kontani K, Teramoto K, Okabe H, Ikegawa S (Jul 2002). "Truncating mutations of RB1CC1 in human breast cancer". Nature Genetics. 31 (3): 285–8. doi:10.1038/ng911. PMID12068296.
Chano T, Ikegawa S, Saito-Ohara F, Inazawa J, Mabuchi A, Saeki Y, Okabe H (May 2002). "Isolation, characterization and mapping of the mouse and human RB1CC1 genes". Gene. 291 (1–2): 29–34. doi:10.1016/S0378-1119(02)00585-1. PMID12095676.
Kontani K, Chano T, Ozaki Y, Tezuka N, Sawai S, Fujino S, Saeki Y, Okabe H (Nov 2003). "RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells". International Journal of Molecular Medicine. 12 (5): 767–9. doi:10.3892/ijmm.12.5.767. PMID14533007.
Bamba N, Chano T, Taga T, Ohta S, Takeuchi Y, Okabe H (Oct 2004). "Expression and regulation of RB1CC1 in developing murine and human tissues". International Journal of Molecular Medicine. 14 (4): 583–7. doi:10.3892/ijmm.14.4.583. PMID15375585.
Watanabe R, Chano T, Inoue H, Isono T, Koiwai O, Okabe H (Sep 2005). "Rb1cc1 is critical for myoblast differentiation through Rb1 regulation". Virchows Archiv. 447 (3): 643–8. doi:10.1007/s00428-004-1183-1. PMID15968549.
Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL (Aug 2005). "Mechanism of cell cycle regulation by FIP200 in human breast cancer cells". Cancer Research. 65 (15): 6676–84. doi:10.1158/0008-5472.CAN-04-4142. PMID16061648.
Chano T, Saji M, Inoue H, Minami K, Kobayashi T, Hino O, Okabe H (Sep 2006). "Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation". International Journal of Molecular Medicine. 18 (3): 425–32. doi:10.3892/ijmm.18.3.425. PMID16865226.
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (Nov 2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID17081983.
Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology. 3 (1): 89. doi:10.1038/msb4100134. PMC1847948. PMID17353931.
Lee YC, Yang VC, Wang TS (Sep 2007). "Use of RAPD to detect sodium arsenite-induced DNA damage in human lymphoblastoid cells". Toxicology. 239 (1–2): 108–15. doi:10.1016/j.tox.2007.06.101. PMID17707572.